Skip to Content
You are currently on the new version of our website. Access the old version .
CancersCancers
  • Article
  • Open Access

14 January 2026

16 Pages

Salvage Interstitial Brachytherapy for Isolated Local Recurrence of Cervical and Endometrial Cancer: A Retrospective Analysis Stratified by Type of Pelvic Irradiation History

,
,
,
,
,
,
,
,
…
1
Department of Radiation Oncology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan
2
Department of Gynecologic Oncology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan
*
Author to whom correspondence should be addressed.

Simple Summary

Pelvic recurrence of cervical and endometrial cancer is challenging to treat, especially in patients with a pelvic irradiation history (PIH). This study analyzed 70 patients treated with salvage interstitial brachytherapy (S-ISBT) for isolated local recurrence. Patients were grouped based on their initial treatment: (Group A) surgery alone, (Group B) surgery + postoperative radiotherapy (RT), or (Group C) definitive RT. Group B demonstrated superior overall survival (OS) and progression-free survival (PFS) compared to Group C. These findings suggest that the type of PIH is a key prognostic factor, and S-ISBT is a particularly viable salvage option for patients with prior postoperative RT.

Abstract

Background/Objectives: This study evaluated the efficacy and safety of salvage interstitial brachytherapy (S-ISBT) for isolated local recurrence (ILR) of cervical and endometrial carcinoma, stratifying patients by pelvic irradiation history (PIH). Methods: Patients with ILR treated with S-ISBT were retrospectively reviewed and categorized by initial treatment: Group A (surgery alone); Group B (surgery + postoperative radiotherapy (RT)); and Group C (definitive RT). Overall survival (OS), progression-free survival (PFS), local control (LC) rates, and the cumulative incidence functions (CIFs) for Grade ≥ 3 late adverse events (AEs) were estimated. Multivariate analysis identified prognostic factors. Results: The study included 70 patients (A: 28, B: 17, C: 25) with a median follow-up of 33.4 months. The 3-year OS, PFS, LC, and CIFs for Grade ≥ 3 late AEs for Groups A, B, and C were 80.8%, 66.7%, and 30.4% (p < 0.001); 56.4%, 41.5%, and 11.6% (p < 0.001); 89.1%, 61.4%, and 43.0% (p = 0.002); and 26.4%, 13.3%, and 32.0% (p = 0.40), respectively. Multivariate analysis suggested the type of PIH, disease-free interval, and tumor volume as independent prognostic factors. While no significant differences were observed between Groups A and B (OS: HR = 0.47, p = 0.19; PFS: HR = 0.60, p = 0.28), Group C exhibited a significantly higher risk than Group B (OS: HR = 3.08, p = 0.018; PFS: HR = 3.41, p = 0.004). Conclusions: S-ISBT could be considered for patients with prior postoperative RT, whose outcomes are significantly better than those with prior definitive RT.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.